(1)
Antimalarials and Macrolides: A Review of off-Label Pharmacotherapies During the First Wave of the SARS-CoV-2 Pandemic. Braz. J. Pharm. Sci. 2023, 59, e21067. https://doi.org/10.1590/s2175-97902023e21067.